BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16929488)

  • 1. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
    Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL
    Mol Carcinog; 2006 Dec; 45(12):934-42. PubMed ID: 16929488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
    Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
    Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress.
    Yang C; Lu W; Lin T; You P; Ye M; Huang Y; Jiang X; Wang C; Wang F; Lee MH; Yeung SC; Johnson RL; Wei C; Tsai RY; Frazier ML; McKeehan WL; Luo Y
    BMC Gastroenterol; 2013 Apr; 13():67. PubMed ID: 23590285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes.
    Ishikawa T; Terai S; Urata Y; Marumoto Y; Aoyama K; Sakaida I; Murata T; Nishina H; Shinoda K; Uchimura S; Hamamoto Y; Okita K
    Cell Tissue Res; 2006 Feb; 323(2):221-31. PubMed ID: 16228231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
    Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid induction of PC3/BTG2 gene by hepatopoietin or partial hepatectomy and its mRNA expression in hepatocellular carcinoma.
    Zhang ZM; Wang G; Chen C; Yang ZX; Jin F; San JL; Xu W; Li Q; Li ZP; Wang D
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):288-93. PubMed ID: 19502170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
    Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
    Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
    Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE
    Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.
    Arbeit JM; Olson DC; Hanahan D
    Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
    Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
    Ho HK; Pok S; Streit S; Ruhe JE; Hart S; Lim KS; Loo HL; Aung MO; Lim SG; Ullrich A
    J Hepatol; 2009 Jan; 50(1):118-27. PubMed ID: 19008009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis.
    Huang X; Yang C; Jin C; Luo Y; Wang F; McKeehan WL
    Mol Carcinog; 2009 Jun; 48(6):553-62. PubMed ID: 19009564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.
    Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
    Wang LH; Huang W; Lai MD; Su IJ
    Carcinogenesis; 2012 Feb; 33(2):466-72. PubMed ID: 22159224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
    Mise M; Arii S; Higashituji H; Furutani M; Niwano M; Harada T; Ishigami S; Toda Y; Nakayama H; Fukumoto M; Fujita J; Imamura M
    Hepatology; 1996 Mar; 23(3):455-64. PubMed ID: 8617424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
    Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
    Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
    Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
    Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
    Yamazaki K; Masugi Y; Sakamoto M
    Dig Dis; 2011; 29(3):284-8. PubMed ID: 21829019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
    Khnykin D; Troen G; Berner JM; Delabie J
    J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.